Adma生物製品 ADMA 深 滬
已收盤 04-02 16:00:00 美东时间
9.19
+0.080
+0.88%
華盛通- 最 高9.255
- 今 開8.90
- 成交量 612.65万股
- 最 低 8.80
- 昨 收 9.11
- 總市值 21.89亿
- 52周最高 25.67
- 市盈率 靜 15.32
- 換手率 2.57%
- 52周最低 7.2101
- 委 比 14.96%
- 總股本 2.38亿
- 歷史最高 25.67
- 量 比 0.38
- 振 幅 4.99%
- 歷史最低 1.01
- 每 手 1
- 風險率 2.60%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BUZZ-Law firm probes short-seller claims at ADMA Biologics; shares up
BUZZ-Law firm probes short-seller claims at ADMA Biologics; shares up ** Shares of biotech firm ADMA Biologics ADMA.O rise 2% to $9.40 premarket ** Securities law firm Bleichmar Fonti & Auld says it is investigating the drugmaker for potential securities law violations ** Probe follows a March 24 re
03-30 18:20
美股周涨跌榜 | 眼科新药临床数据大超预期，KOD周涨超 66%；OLPX 周涨近52%
药企并购潮来袭！Apellis制药飙升135%，获高额溢价收购；SpaceX已递交上市申请！FLY周涨38%，公司为NASA新一代登月火箭供应商；CNTA周涨38%，公司获礼来收购>>
03-28 11:01
What's Behind The Jump In Vor Biopharma Stock?
Shares of Vor Biopharma Inc. (NASDAQ: VOR) are trading higher Friday after pricing a $14.05 private placement of 5.4 million shares.
03-27 23:15
ADMA Biologics gains after refuting short seller claims
ADMA Biologics (ADMA) rose 15% after refuting claims from a Culper Research short report. "ADMA believes that by providing, on a non-recurring basis, additional details concerning the Company’s immun...
03-27 21:44
期权扫描 | 一看跌期权大涨4642%，Meta期权成交激增2.4倍；短线投机失败？特斯拉一巨量看涨期权腰斩
一看跌期权大涨4642%，Meta期权成交激增2.4倍；短线投机失败？特斯拉一巨量看涨期权腰斩；看涨期权占比攀升至75%，亚马逊获小摩上调目标价>>
03-27 19:47
ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research
ADMA Biologics refutes a short seller's report, highlighting that demand for its ASCENIV product has steadily increased over the past two years, reaching record highs. The company emphasizes that inventory levels maintained by its distributors align with industry standards and reflect the long production cycle for ASCENIV. ADMA also clarifies that ASCENIV is positioned as a late-line therapy for immune-compromised patients, commanding premium pri...
03-27 11:00
Why Are Shares Of ADMA Biologics Falling Today?
ADMA Biologics, Inc. (NASDAQ: ADMA) shares are tumbling on Thursday as traders lean into risk-off positioning and punish weaker charts in a down tape. The Nasdaq is down 0.91% while the S&P 500 has shed 0.57%, and ADMA is moving with the broader market decline but with heavier downside pressure than the major indices.
03-27 00:34
This Qualcomm Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
Wall Street analysts changed outlook on top names. View all changes on analyst ratings page. See what analysts think about QCOM stock.
03-26 19:31
Cantor Fitzgerald Downgrades ADMA Biologics to Neutral
Cantor Fitzgerald analyst Kristen Kluska downgrades ADMA Biologics (NASDAQ:ADMA) from Overweight to Neutral.
03-26 18:00
Short Seller Report Alleges ADMA Biologics Financial Misrepresentation
ADMA Biologics shares drop after Culper Research short report alleges financial misreporting; company pushes back.
03-26 01:22
